Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-063963

Chief Executive Officer sold 90,000 shares at $13.92 ($1,252,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2018-12-19 Sale −90,000 $13.92 $1,252,800 1,542,455 D
Open-market sales · 90,000 sh · avg $13.92 · $1,252,800
Loading xslF345X03/doc4.xml…